| Independent Reports (Showing 1 to 5 of 5) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 6-Feb-10 | Standard & Poor's Quantitative Report | N/A | Transcept Pharmaceuticals | 6 | $25 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Value Graph: TRANSCEPT PHARMA -- TSPT | 1 | $4 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ANX , MIPI , STEM , TSPT -- DRUGS | 3 | $4 | View Abstract |
| 12-Jan-10 | EconomicInvestor | N/A | "The Economy Matters" Report for TSPT: the economy's impact on TSPT's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 | $15 | View Abstract |
| 8-Jan-10 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of TRANSCEPT PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 | $20 | View Abstract |